Delivery Order SPE2DB22D9353-SPE2DB25FX2EC
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at approximately $390K by the Defense Logistics Agency's Medical Supply Chain for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on September 23, 2025, is expected to be completed by October 15, 2025, and represents a continuation of the company's substantial role as a critical supplier within the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $40,179.29 by the Defense Logistics Agency on September 15, 2025. This delivery order, with an ultimate completion date of October 6, 2025, covers the supply of Stelara 90 mg/mL syringes to support Department of Defense healthcare operations. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,249.95 on August 19, 2025, for the supply of Stelara 90 mg/ml syringes. The delivery order, which carries a firm fixed price and is not subject to any set-aside designation, is funded by the Defense Logistics Agency's Medical Supply Chain division and must be completed by September 10, 2025. This award represents a single delivery order...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on September 8, 2025. The delivery order, which has an ultimate completion date of September 29, 2025, is for Stelara 90 mg/ml syringes—a prescription biologic medication used to treat autoimmune and inflammatory conditions. This award was issued without a set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $32,499.90 on August 13, 2025, by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, which is scheduled for completion by September 4, 2025, represents a continuation of the company's substantial role as a critical supplier within the federal pharmaceutical supply chain. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 24, 2025, for Stelara 90 mg/ml syringes valued at $32,499.90. This firm fixed-price delivery order, which is set to be completed by August 14, 2025, was issued without a set-aside designation, allowing the contractor to compete on an unrestricted basis. The award falls under DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on June 3, 2025. The delivery order, which carries an ultimate completion date of June 25, 2025, covers the supply of Stelara 90 mg/ml syringes for distribution to military healthcare facilities. This award was issued without a set-aside designation, allowing the vendor to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $65,000 for Stelara 90 mg/ml syringes on June 17, 2025, with completion scheduled for July 10, 2025. This firm fixed-price delivery order was issued without set-aside designation and is funded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The award represents a continuation of DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency's Medical Supply Chain on August 1, 2025. The delivery order is for Stelara 90 mg/ml syringes, with an ultimate completion date of August 22, 2025. This award carries no set-aside designation, allowing the vendor to compete on its merits within the broader federal procurement...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency on September 9, 2025. The award is for the supply of Stelara 90 mg/mL syringes, a biologic medication used to treat autoimmune conditions. This firm fixed-price delivery order is scheduled for completion by September 30, 2025, with no set-aside designation applied. The contract leverages DMS...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX2ECDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $65K by the Defense Logistics Agency on September 5, 2025, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order is expected to be completed by September 26, 2025, and represents a continuation of the company's ongoing pharmaceutical supply relationship with the federal government. The award carries no set-aside designation, reflecting DMS Pharmaceutical Group's competitive standing in the federal procurement market despite its small business status. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $500M and valid through November 2026. The IDC, established under the SPE2DB program, enables the Defense Logistics Agency to issue firm fixed-price delivery orders for pharmaceutical products supporting military healthcare facilities nationwide. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides an extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites, with this Stelara order representing a specialized pharmaceutical delivery supporting military medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $65.0k | 9/5/25 |